Cargando…
PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction
The biological function of nuclear PAK4 in ERα-positive breast cancer osteolytic bone destruction remains unclear. Here, we find that the nuclear PAK4 promotes osteoclastogenesis and tumor-induced osteolysis via phosphorylating RUNX1. We show that nuclear PAK4 interacts with and phosphorylates RUNX1...
Autores principales: | Tang, Lina, Gao, Yunling, Song, Yongqi, Li, Yang, Li, Yanshu, Zhang, Hongyan, Li, Danni, Li, Jiabin, Liu, Caigang, Li, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294946/ https://www.ncbi.nlm.nih.gov/pubmed/32549768 http://dx.doi.org/10.7150/ijbs.47225 |
Ejemplares similares
-
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
por: Li, Yanshu, et al.
Publicado: (2018) -
PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis
por: Xing, Yao, et al.
Publicado: (2021) -
The Molecular Mechanism of Traditional Chinese Medicine Prescription: Gu-tong Formula in Relieving Osteolytic Bone Destruction
por: Chang, Jinyuan, et al.
Publicado: (2022) -
A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells
por: Liu, Funan, et al.
Publicado: (2017) -
Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)